The global GERD market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Gastroesophageal reflux disease involves the backflow of stomachs content to mouth through esophagus which gives a burning sensation behind breast bone. Gastroesophageal reflux disease is a common digestive disorder which affects the food pipe and lower esophageal sphincter by deteriorating its elasticity. Gastroesophageal reflux disease occurs due to lifestyle changes and irregular eating habits & over consumption of fatty foods, coffee, alcoholic beverages, citrus fruits and pepper. In Gastroesophageal reflux disease there is excessive production of acid which damages the stomach lining and ultimately cause ulcers. Gastroesophageal reflux disease includes other symptoms such as regurgitation and dysphagia. However, abnormal reflux may cause uncharacteristic symptoms such as coughing, sore throat, otitis media, chest pain and enamel erosion or other dental manifestations.

The overall market has been experiencing a downturn in terms of revenue in the past several years as the leading drugs for GERD treatment have lost their patent protection, with their market shares now largely consumed by over-the-counter (OTC) and generic medications. Although loss of exclusivity of high-grossing drugs have caused a market fall-off, the demand for acid reducing drugs due to the high prevalence and incidence levels of GERD will prove beneficial to the industry from a commercial standpoint. GERD is one of the commonly observed recurrent gastrointestinal disorders worldwide. The prevalence of acid reflux and related symptoms has increased across the globe by nearly 50% over the last decade. This disorder not only has major effects on the health and quality of patient lives, but also extends to the healthcare system and economy.

Infinity Market Research newest research report, the GERD Industry Forecast looks at past sales and reviews total world GERD sales in 2024, providing a comprehensive analysis by region and market sector of projected GERD sales for 2025 through 2031. With GERD sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GERD industry.

This Insight Report provides a comprehensive analysis of the global GERD landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GERD portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global GERD market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GERD and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GERD.

This report presents a comprehensive overview, market shares, and growth opportunities of GERD market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Proton Pumps Inhibitors
    H2 Receptor Antagonists
    Antacids
    Prokinetics
    CAM

Segmentation by Application:

    Hospital Pharmacy
    Drug Stores
    General Stores
    Supermarkets

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    AstraZeneca
    Eisai
    GlaxoSmithKline
    Johnson & Johnson
    Takeda

Key Questions Addressed in this Report

What is the 10-year outlook for the global GERD market?
What factors are driving GERD market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do GERD market opportunities vary by end market size?
How does GERD break out by Type, by Application?